HemaClear (OHK Medical Devices)

What HemaClear (OHK Medical Devices) does

HemaClear, the trade name of OHK Medical Devices, is a privately held U.S. medical device company founded in 2002 and headquartered in Grandville, Michigan. The company manufactures and distributes a sterile, single-use exsanguination tourniquet — a pre-sized elastic ring that, when applied, simultaneously exsanguinates the limb and occludes arterial inflow to create a bloodless surgical field for orthopedic extremity procedures in approximately 12 seconds. The device is positioned as a single-step replacement for the traditional combination of an Esmarch bandage (for exsanguination) and a pneumatic tourniquet cuff, and is sold as a sterile disposable consumable that is consumed one unit per procedure.

The company's commercial model is therefore consumables-driven: revenue is generated per orthopedic case, with the device sold through medical-surgical distribution into hospitals and ambulatory surgery centers rather than directly to end consumers. Customers are healthcare providers performing extremity orthopedic surgery (hand, foot, upper- and lower-limb procedures), and the recurring unit demand is tied to procedure volume at those facilities. Headcount of 11-50 employees is consistent with a focused, founder-controlled niche medical device business rather than a venture-backed scale operation; the input does not show any institutional funding rounds, acquisitions, or recent leadership changes beyond the listed Chief Medical Officer (Noam Gavriely).

Operationally the company appears to be a small, established, specialty medical device manufacturer whose competitive position depends on its proprietary sterile ring design and the regulatory clearances that permit sterile disposable surgical products to be sold into hospital OR environments. No product, technology, partnership, or geographic-expansion details were extractable from the available primary sources beyond the firmographic and leadership fields summarized above, which limits the ability to characterize the current state of its commercial footprint or pipeline.

Name

HemaClear (OHK Medical Devices)

Website

https://hemaclear.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

HemaClear, the trade name of OHK Medical Devices, manufactures and distributes a sterile, single-use exsanguination tourniquet that prepares a bloodless surgical field for orthopedic procedures in about 12 seconds, serving hospitals and ambulatory surgery centers performing extremity orthopedic surgery.

Ownership category

akta.pro rank

Product category

Orthopedic Surgical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

Keywords

• Sterile exsanguination tourniquet
• Orthopedic surgical devices
• Medical tourniquet systems
• Surgical blood management
• Single-use surgical devices

Headquarters

HQ city

Grandville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel

Core offering

HemaClear, marketed by OHK Medical Devices, is a sterile, single-use exsanguination tourniquet device designed to prepare patients for orthopedic surgical procedures in approximately 12 seconds. The product is intended to provide a rapid, sterile surgical field for orthopedic and other surgical applications by exsanguinating the limb and occluding blood flow without the need for conventional reusable tourniquet equipment.

Product overview

Unable to extract product information from available source data. The source content shows a loading/verification page with no substantive product, service, or company information.

Differentiator

Problem solved

Functional benefit

Products and services

• HemaClear Sterile, single-use exsanguination tourniquet device that prepares patients for orthopedic surgical procedures in approximately 12 seconds by exsanguinating the limb and providing a bloodless surgical field; intended for use by surgical teams in hospitals, ambulatory surgical centers, and orthopedic practices.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Broad incumbents

• Stryker: Large diversified orthopedic medical-device company with surgical instruments, tourniquet systems, and broader OR capital equipment. Competes for the same orthopedic surgery budgets and is a broad incumbent in this category.
• Smith+Nephew: Orthopedic and sports-medicine device manufacturer with surgical instruments, extremity products, and OR-supporting technologies. Overlaps with HemaClear at the orthopedic-procedure level.
• Zimmer Biomet: Global orthopedic device leader with surgical instruments, implants, and OR-supporting products. Competes with HemaClear via bundled surgical-preparation offerings in orthopedic procedures.
• Getinge: Provider of surgical equipment, perfusion systems, and OR workflow solutions for hospitals. Adjacent to HemaClear's pre-op blood-management niche within surgical workflows.
• BD (Becton, Dickinson and Company): Large medical-technology company with surgical and perioperative product portfolios that interface with orthopedic OR workflows. Competes for hospital contracting share against HemaClear's niche devices.

Direct peers

• Delfi Medical Innovations: Manufacturer of pneumatic tourniquet systems and surgical tourniquet instruments used in orthopedic and limb surgery. Directly comparable to HemaClear as both companies sell tourniquet/exsanguination devices into the same OR workflow.
• VBM Medizintechnik: German manufacturer of pneumatic tourniquets and sterile exsanguination tourniquet devices (including elastic ring tourniquets) for surgical blood-occlusion applications. A direct competitor in the tourniquet/exsanguination category.
• Anetic Aid: UK-based manufacturer of tourniquet equipment and patient-preparation devices used in operating rooms. Overlaps directly with HemaClear's orthopedic pre-op positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/HemaClear
• Facebookfacebook.com/HemaClear
• LinkedInlinkedin.com/company/ohk-medical-devices

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HemaClear (OHK Medical Devices)